LADENBURG THALMANN FINANCIAL SERVICES INC. - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 59 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q3 2019$8,0000.0%9,995
+5.3%
0.00%
Q2 2019$8,000
+33.3%
9,495
+35.7%
0.00%
Q1 2019$6,0000.0%6,9950.0%0.00%
Q4 2018$6,000
-53.8%
6,9950.0%0.00%
Q3 2018$13,000
+62.5%
6,995
+70.8%
0.00%
Q2 2018$8,0000.0%4,0950.0%0.00%
Q1 2018$8,000
+14.3%
4,095
+104.8%
0.00%
Q3 2016$7,0000.0%2,0000.0%0.00%
Q2 2016$7,000
-73.1%
2,0000.0%0.00%
Q1 2015$26,0002,0000.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,492,975$3,571,915,0001.18%
&PARTNERS 51,961$41,0000.06%
Glassman Wealth Services 72,366$58,0000.02%
Sigma Planning Corp 385,737$307,0000.02%
Psagot Value Holdings Ltd. 310,096$247,0000.01%
HBK Sorce Advisory LLC 100,000$80,0000.01%
B. Riley Wealth Management, Inc. 48,800$39,0000.01%
Fore Capital, LLC 112,600$90,0000.01%
WealthTrust Axiom LLC 17,320$13,0000.01%
Semmax Financial Advisors Inc. 7,290$6,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders